The question is whether it delivers the intended benefits and whether it's safe
Therefore, the implementation of a combined pharmacological therapy acting via different pathways becomes necessary, and its combination with a compound of the sulfonylurea group was along decades the most frequently employed prescription in routine clinical practice
Interestingly, a triple GLP-1/GIP/glucagon receptor agonist was found to have neuroprotective effects on a transgenic mouse model of Alzheimers disease, as drug treatment increased neurogenesis and reversed memory deficit
Each receptor contributes something different
Diabetes mellitus, type 2
Significant weight loss typically begins within the first month, with clinical studies showing average weight loss of 15-20% over 6-12 months with consistent treatment and lifestyle modifications